Your browser doesn't support javascript.
loading
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.
Darman, Rachel B; Seiler, Michael; Agrawal, Anant A; Lim, Kian H; Peng, Shouyong; Aird, Daniel; Bailey, Suzanna L; Bhavsar, Erica B; Chan, Betty; Colla, Simona; Corson, Laura; Feala, Jacob; Fekkes, Peter; Ichikawa, Kana; Keaney, Gregg F; Lee, Linda; Kumar, Pavan; Kunii, Kaiko; MacKenzie, Crystal; Matijevic, Mark; Mizui, Yoshiharu; Myint, Khin; Park, Eun Sun; Puyang, Xiaoling; Selvaraj, Anand; Thomas, Michael P; Tsai, Jennifer; Wang, John Y; Warmuth, Markus; Yang, Hui; Zhu, Ping; Garcia-Manero, Guillermo; Furman, Richard R; Yu, Lihua; Smith, Peter G; Buonamici, Silvia.
Afiliación
  • Darman RB; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Seiler M; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Agrawal AA; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Lim KH; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Peng S; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Aird D; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Bailey SL; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Bhavsar EB; Department of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10020, USA.
  • Chan B; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Colla S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Corson L; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Feala J; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Fekkes P; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Ichikawa K; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Keaney GF; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Lee L; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Kumar P; Eisai, Inc., Andover, MA 01810, USA.
  • Kunii K; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • MacKenzie C; Eisai, Inc., Andover, MA 01810, USA.
  • Matijevic M; Eisai, Inc., Andover, MA 01810, USA.
  • Mizui Y; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Myint K; Eisai, Inc., Andover, MA 01810, USA.
  • Park ES; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Puyang X; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Selvaraj A; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Thomas MP; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Tsai J; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Wang JY; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Warmuth M; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Yang H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhu P; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Furman RR; Department of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10020, USA.
  • Yu L; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Smith PG; H3 Biomedicine, Inc., Cambridge, MA 02139, USA.
  • Buonamici S; H3 Biomedicine, Inc., Cambridge, MA 02139, USA. Electronic address: silvia_buonamici@h3biomedicine.com.
Cell Rep ; 13(5): 1033-45, 2015 Nov 03.
Article en En | MEDLINE | ID: mdl-26565915
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Fosfoproteínas / Ribonucleoproteína Nuclear Pequeña U2 / Empalme Alternativo / Mutación / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Fosfoproteínas / Ribonucleoproteína Nuclear Pequeña U2 / Empalme Alternativo / Mutación / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos